Latest Breaking News On - Javad aman - Page 1 : comparemela.com
LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc s Innovative Vaccine Candidate Against Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Emerging Infectious Diseases Prompt a Layered Response
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Panelist Bios:
Javad Aman, Ph.D., has over 30 years of experience in the fields of immunology, microbiology, and vaccine development. A highly accomplished scientist, Dr. Aman has published over 100 scientific articles, including many in highly prestigious journals, such as Cell, Science, and Proceeding of the National Academy of Sciences.
Dr. Aman has made important discoveries, such as the receptor for human interleukin-13 as well as small molecule inhibitors and monoclonal antibodies for Ebola and Marburg viruses. In 2007, he founded the research-based company Integrated Biotherapeutics (IBT), where he and his staff develop vaccines and antibody therapeutics for emerging infectious diseases. The company has thus far received nearly $80 million of research funding from the US government and prestigious funding agencies.